News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,332 Results
Type
Article (64112)
Company Profile (483)
Press Release (677725)
Multimedia
Podcasts (158)
Webinars (23)
Section
Business (195012)
Career Advice (3423)
Deals (35249)
Drug Delivery (139)
Drug Development (85472)
Employer Resources (187)
FDA (17562)
Job Trends (15264)
News (344042)
Policy (35956)
Tag
Academia (2953)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (129)
Alliances (50581)
ALS (146)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (267)
Approvals (17599)
Artificial intelligence (467)
Autoimmune disease (104)
Automation (30)
Bankruptcy (371)
Best Places to Work (11851)
BIOSECURE Act (23)
Biosimilars (166)
Biotechnology (327)
Bladder cancer (139)
Brain cancer (52)
Breast cancer (525)
Cancer (4149)
Cardiovascular disease (362)
Career advice (2915)
Career pathing (37)
CAR-T (259)
CDC (57)
Cell therapy (705)
Cervical cancer (33)
Clinical research (71259)
Collaboration (1441)
Company closure (4)
Compensation (966)
Complete response letters (63)
COVID-19 (2939)
CRISPR (85)
C-suite (618)
Cystic fibrosis (142)
Data (4945)
Decentralized trials (2)
Denatured (52)
Depression (111)
Diabetes (462)
Diagnostics (6773)
Digital health (36)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (225)
Drug pricing (193)
Drug shortages (36)
Duchenne muscular dystrophy (209)
Earnings (77845)
Editorial (55)
Employer branding (22)
Employer resources (162)
Events (120694)
Executive appointments (969)
FDA (20133)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1289)
Gene editing (181)
Generative AI (39)
Gene therapy (564)
GLP-1 (1029)
Government (5187)
Grass and pollen (8)
Guidances (369)
Healthcare (19889)
HIV (46)
Huntington's disease (41)
IgA nephropathy (68)
Immunology and inflammation (256)
Immuno-oncology (22)
Indications (60)
Infectious disease (3187)
Inflammatory bowel disease (191)
Inflation Reduction Act (15)
Influenza (101)
Intellectual property (200)
Interviews (665)
IPO (16722)
IRA (59)
Job creations (3812)
Job search strategy (2368)
Kidney cancer (16)
Labor market (78)
Layoffs (626)
Leadership (36)
Legal (8569)
Liver cancer (92)
Longevity (12)
Lung cancer (589)
Lymphoma (286)
Machine learning (31)
Management (63)
Manufacturing (657)
MASH (146)
Medical device (14080)
Medtech (14106)
Mergers & acquisitions (19453)
Metabolic disorders (1184)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (237)
Neuropsychiatric disorders (62)
Neuroscience (2754)
NextGen: Class of 2025 (7056)
Non-profit (4847)
Now hiring (49)
Obesity (576)
Opinion (312)
Ovarian cancer (143)
Pain (173)
Pancreatic cancer (177)
Parkinson's disease (245)
Partnered (28)
Patents (430)
Patient recruitment (341)
Peanut (57)
People (58328)
Pharmaceutical (89)
Pharmacy benefit managers (29)
Phase I (22101)
Phase II (31176)
Phase III (23573)
Pipeline (2916)
Policy (303)
Postmarket research (2895)
Preclinical (9628)
Press Release (69)
Prostate cancer (205)
Psychedelics (52)
Radiopharmaceuticals (281)
Rare diseases (713)
Real estate (6146)
Recruiting (75)
Regulatory (25940)
Reports (50)
Research institute (2654)
Resumes & cover letters (545)
Rett syndrome (17)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (160)
Service/supplier (13)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (163)
Sponsored (42)
Startups (3733)
State (2)
Stomach cancer (17)
Supply chain (101)
Tariffs (96)
The Weekly (105)
Vaccines (1054)
Venture capital (69)
Weight loss (403)
Women's health (57)
Worklife (21)
Date
Today (296)
Last 7 days (1060)
Last 30 days (3284)
Last 365 days (32611)
2025 (27705)
2024 (37013)
2023 (41641)
2022 (52833)
2021 (57445)
2020 (55782)
2019 (48569)
2018 (36862)
2017 (34903)
2016 (34814)
2015 (39967)
2014 (33008)
2013 (27889)
2012 (29738)
2011 (29995)
2010 (28001)
Location
Africa (1033)
Alabama (80)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (44037)
Australia (7657)
California (9767)
Canada (2887)
China (943)
Colorado (402)
Connecticut (435)
Delaware (273)
Europe (102017)
Florida (1452)
Georgia (315)
Hawaii (3)
Idaho (63)
Illinois (776)
India (52)
Indiana (451)
Iowa (20)
Japan (333)
Kansas (122)
Kentucky (38)
Louisiana (21)
Maine (79)
Maryland (1302)
Massachusetts (7339)
Michigan (297)
Minnesota (562)
Mississippi (3)
Missouri (115)
Montana (30)
Nebraska (21)
Nevada (104)
New Hampshire (79)
New Jersey (2714)
New Mexico (32)
New York (2642)
North Carolina (1395)
North Dakota (10)
Northern California (4564)
Ohio (299)
Oklahoma (22)
Oregon (40)
Pennsylvania (2021)
Puerto Rico (19)
Rhode Island (42)
South America (1398)
South Carolina (50)
South Dakota (1)
Southern California (3739)
Tennessee (146)
Texas (1505)
United States (35684)
Utah (292)
Virginia (235)
Washington D.C. (81)
Washington State (823)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
742,332 Results for "the parkinson s institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease.
September 2, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
October 9, 2025
·
8 min read
Press Releases
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
October 7, 2025
·
7 min read
Press Releases
Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
October 3, 2025
·
7 min read
Press Releases
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
October 6, 2025
·
3 min read
Press Releases
ABLi Therapeutics Reports Final Results from the Phase 2 ‘201 Trial’ Evaluating Risvodetinib for the Treatment of Parkinson’s Disease
October 10, 2025
·
5 min read
Press Releases
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
September 23, 2025
·
8 min read
Press Releases
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
October 7, 2025
·
8 min read
Press Releases
First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease
September 23, 2025
·
12 min read
Press Releases
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
October 9, 2025
·
13 min read
1 of 74,234
Next
